Dishman Pharma Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Dishman Pharma Quarterly Results    (DHPH)

Here are the latest quarterly results of Dishman Pharma. For more details, see the Dishman Pharma financial fact sheet and Dishman Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Dishman Pharma Quarterly Results

No. of Mths
Qtr. Ending
3
Jun-15
*
3
Sep-15
*
3
Dec-15
*
3
Mar-16
*
3
Jun-16
*
3
Sep-16
*
3
Dec-16
*
3
Mar-17
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m4,0053,8123,8874,2213,7544,3663,6215,342 
Other income Rs m417617130707715538 
Turnover Rs m4,0473,8883,9044,3513,8244,4423,7765,380 
Expenses Rs m2,9612,8972,7873,1752,7323,2082,6643,875 
Gross profit Rs m1,0449151,1001,0461,0221,1589531,462 
Depreciation Rs m259261271299285309293570 
Interest Rs m319236185205225189134101 
Profit before tax Rs m507494661672583736682829 
Tax Rs m130129191174127190175401 
Profit after tax Rs m378365469498455547507428 
Gross profit margin %26.124.028.324.827.226.526.327.4 
Effective tax rate %25.626.129.025.821.925.825.748.4 
Net profit margin %9.49.612.111.812.112.514.08.0 
Diluted EPS Rs 2.3 2.3 2.9 3.1 2.8 3.4 3.1 2.7  
Diluted EPS (TTM) Rs 8.3 8.5 9.9 10.6 11.1 12.2 12.4 12.0  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

More Pharmaceuticals Company Quarterly Results:   ALKEM LABORATORIES  WYETH  SANOFI INDIA  BIOCON   WOCKHARDT  

Compare DISHMAN PHARMA With:   ALKEM LABORATORIES  WYETH  SANOFI INDIA  BIOCON   WOCKHARDT  

Compare DISHMAN PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Flat; Wipro & Hindalco Industries Among Top Nifty Gainers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Views on news

Most Popular

India: Recovery Stalled by Vaccine Games? (The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

4 Stocks to Make Your Portfolio Immune to the Second Covid Wave (Profit Hunter)

Apr 6, 2021

Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.

A Stock with 700% Return Potential Comes with Additional Payoffs (Profit Hunter)

Apr 15, 2021

Narayana Murthy was one of the first unicorn founders to get the backing of this entity...

Why Did the Market Crash on Monday? (Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

A Unique Sector for Short-Term Profits (Fast Profits Daily)

Apr 12, 2021

This ignored sector could deliver big short-term profits.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

DISHMAN PHARMA SHARE PRICE


May 29, 2017 (Close)

TRACK DISHMAN PHARMA

  • Track your investment in DISHMAN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DISHMAN PHARMA

DISHMAN PHARMA - TEVA PHARMA COMPARISON

COMPARE DISHMAN PHARMA WITH

MARKET STATS